Knowledge, attitudes, and behaviors regarding piperacillin-tazobactam prescribing practices: results from a multicenter study.
We investigated knowledge, attitudes, and behaviors of prescribers concerning piperacillin-tazobactam use at 4 Emory University-affiliated hospitals. Discussions during focus groups indicated that the participants' perceived knowledge of clinical criteria for appropriate piperacillin-tazobactam use was inadequate. Retrospective review of medical records identified inappropriate practices. These findings have influenced ongoing interventions aimed at optimizing piperacillin-tazobactam use.
Antoine
Theresa L
TL
Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. tantoine@cdc.gov
Curtis
Amy B
AB
Blumberg
Henry M
HM
Desilva
Kathryn
K
Fransua
Mesfin
M
Gould
Carolyn V
CV
King
Mark
M
Kraman
Alice A
AA
Pack
Jan
J
Ribner
Bruce
B
Seybold
Ulrich
U
Steinberg
James P
JP
Wells
Jane B
JB
Sinkowitz-Cochran
Ronda L
RL
Cardo
Denise
D
Jernigan
John A
JA
Gaynes
Robert P
RP
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004363:Drug Utilization / Q000706:statistics & numerical data*; D017144:Focus Groups; D007722:Health Knowledge, Attitudes, Practice; D006785:Hospitals, University; D006801:Humans; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D018461:Soft Tissue Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin